Aprea Therapeutics Inc. (APRE): A higher price at closing charts some po...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	6
Posts	85
Boards Moderated	0
Alias Born	04/29/2020

RockStarInvestor

Re: None

Tuesday, 01/12/2021 12:29:35 AM

Tuesday, January 12, 2021 12:29:35 AM

A higher price at closing charts some positive momentum. The after hours continued the trend. Hopefully this stock will begin to grow at higher levels and a new higher resistance base is formed. Fingers and toes crossed. This is the bottom.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent APRE News

Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 10:01:02 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/05/2024 05:15:27 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:26:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:13:27 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/26/2024 11:03:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:16:01 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/09/2023 09:20:51 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:15:35 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:33 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:29:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 11:31:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 12:30:20 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:52:29 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:50:02 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 01:48:22 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/24/2023 12:00:28 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 11:39:02 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 11:36:21 AM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/11/2023 11:30:29 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/05/2023 08:01:07 PM
Aprea Therapeutics to Present at Maxim Virtual Healthcare Conference • GlobeNewswire Inc. • 06/14/2023 12:00:00 PM
Aprea Therapeutics to Present at BIO International Convention • GlobeNewswire Inc. • 05/30/2023 12:30:00 PM
Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations • GlobeNewswire Inc. • 05/15/2023 08:05:00 PM

More APRE News

InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover